药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Fenoldopam
Ketanserin
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Ketanserin.
Fenoldopam
Orvepitant
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Orvepitant.
Fenoldopam
Bromperidol
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Bromperidol.
Fenoldopam
Esreboxetine
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Esreboxetine.
Fenoldopam
Piclozotan
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Piclozotan.
Fenoldopam
Carisbamate
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Carisbamate.
Fenoldopam
Salvinorin A
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Salvinorin A.
Fenoldopam
Eltanolone
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Eltanolone.
Fenoldopam
Ecopipam
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Ecopipam.
Fenoldopam
Cerlapirdine
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Cerlapirdine.
Fenoldopam
Gepirone
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Gepirone.
Fenoldopam
Eplivanserin
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Eplivanserin.
Fenoldopam
Sarpogrelate
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Sarpogrelate.
Fenoldopam
MK-212
The risk or severity of adverse effects can be increased when Phenobarbital is combined with MK-212.
Fenoldopam
m-Chlorophenylpiperazine
The risk or severity of adverse effects can be increased when Phenobarbital is combined with m-Chlorophenylpiperazine.
Fenoldopam
Imagabalin
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Imagabalin.
Fenoldopam
Vabicaserin
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Vabicaserin.
Fenoldopam
Idalopirdine
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Idalopirdine.
Fenoldopam
Lanicemine
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Lanicemine.
Fenoldopam
Etiracetam
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Etiracetam.